Goldenarticles articles

Governing body finance agency delays fda agreement of vagus nerve stimulation therapy for depression - depression

 

On June 15th, 2004, FDA's Health Plans Panel suggested that the U. S. Food and Drug Administration agree vagus nerve stimulation as a therapy for constant or continual treatment-resistant depression. I was at the meeting, seated in the first row and made a presentation to the Panel.

Yet, one year later, we still do not have a final admiration from the U. S. Food and Drug Admin (FDA).

What's the delay? Senator Chuck Grassley, Chairman of the Committee Finance Committee, unexpectedly certain to analyze the FDA's certitude to allow this therapy to be used to treat depression. Vagus nerve stimulation therapy has been FDA accepted for epilepsy for eight years. Even if this is not a conventional investigation, it is actually an barrier to the direct issuance of FDA's final approval. I am not aware of the Governing body Finance Committee's methodical and medicinal credentials. However, I do have first-hand comprehension of a number of FDA Checkup Apparatus Panel Members lack of familiarity with the FDA's own rules and guidelines.

If you would like to convey your outrage at the continual delay of final FDA approval, desire contact:

U. S. Board Board on Finance
219 Dirksen Committee Company Construction
Washington, DC 20510-6200
Sen. Grassley Staff: (202) 224-4515
Sen. Baucus Staff: (202) 224-5315

Senator Chuck Grassley
Chairman, Board Finance Board
135 Hart Governing body Construction
Washington, DC 20510-1501
(202) 224-3744 Call up
Web Link for e-mail: http://grassley. senate. gov/index. cfm?FuseAction=Contact. Home

Ironically, this one-year anniversary coincides with the issuance of a $20 million attraction study sponsored by the Citizen Institute of Mental Health. This is the most across-the-board mental physical condition study undertaken by the government. The study reported that 25% of Americans suffered a psychiatric disorder in the year prior to the survey, but most disastrous to get passable care. Dr. Thomas Insel, Boss of the Citizen Institute of Mental Healthiness commented that "mental disorders are approvingly prevalent and chronic. " As expected, researchers found that the most collective disorder was depression. Depression typically ongoing in early adulthood, 20's and 30's, and little by little got worse and more challenging to treat. If you endure from frequent or treatment-resistant depression, you don't need a $20 million examine study to tell you that depression is arduous to treat.

Charles Donovan was a long-suffering in the FDA investigational trial for vagus nerve stimulation and depression. He testified to the Panel at the Advisory Conference on June 15th, 2004. After 25 years of ever-present depression, vagus nerve stimulation absolutely cured his frequent depression. The creator is most gratifying and humbled by this remarkable device. Learn more at his website: http://www. VagusNerveStimulator. com or read about this life-saving, life varying therapy in his book:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression.

It is accessible at on Amazon. com, Barnes & Noble. com, 1-888-VAGUS-88 or on his web site, http://www. vagusnervestimulator. com/book/


MORE RESOURCES:





















Can Mindfulness Help When You're Depressed?  Greater Good Science Center at UC Berkeley


Why Is America So Depressed?  The New York Times














































When Depression Is Like a Cancer  The New York Times












Dark Chocolate for Depression  Psychiatric Times



Battling Depression from the C-Suite  Harvard Business Review
















Developed by:
home | site map
goldenarticles.net © 2020